Hongda Lu

1.6k total citations
25 papers, 685 citations indexed

About

Hongda Lu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hongda Lu has authored 25 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hongda Lu's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (6 papers). Hongda Lu is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers) and RNA modifications and cancer (6 papers). Hongda Lu collaborates with scholars based in China and United States. Hongda Lu's co-authors include Qingzhi Kong, Wenlong Wang, Weiqun Chen, Yao Chen, Nicholas W. Mathy, Zhongxin Lu, Weiyang Lou, Bisha Ding, Beng Yang and Weimin Fan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and FEBS Letters.

In The Last Decade

Hongda Lu

25 papers receiving 676 citations

Peers

Hongda Lu

PRM

ONCOL

PFM

Zhiming Wang China

Harald Surowy Germany

Shengsheng Yang China

Michał Świerniak Poland

Dong Qian China

Yongfeng Wu China

Jue‐Yu Zhou China

Tzu‐Ju Chen Taiwan

Heather Hardin United States

Małgorzata Jarmuż‐Szymczak Poland

Zhiming Wang China

Hongda Lu

402 ×0.9

320 ×0.9

80 ×0.7

PRM

154 ×1.4

ONCOL

42 ×0.7

PFM

Citations per year, relative to Hongda Lu Hongda Lu (= 1×) peers Zhiming Wang

Countries citing papers authored by Hongda Lu

Since Specialization

Citations

This map shows the geographic impact of Hongda Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongda Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongda Lu more than expected).

Fields of papers citing papers by Hongda Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongda Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongda Lu. The network helps show where Hongda Lu may publish in the future.

Co-authorship network of co-authors of Hongda Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongda Lu. A scholar is included among the top collaborators of Hongda Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongda Lu. Hongda Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Hongda, et al.. (2024). LINC00963 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma by Interacting with miR-10a to Upregulate SKA1 Expression. Applied Biochemistry and Biotechnology. 196(10). 7219–7232. 5 indexed citations

Lu, Chi‐Cheng, et al.. (2023). Porphyromonas gingivalis lipopolysaccharide regulates cell proliferation, apoptosis, autophagy in esophageal squamous cell carcinoma via TLR4/MYD88/JNK pathway. Journal of Clinical Biochemistry and Nutrition. 74(3). 213–220. 4 indexed citations

Xu, Lin, et al.. (2022). Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma via the PI3K/AKT pathway. World Journal of Gastroenterology. 28(4). 464–478. 9 indexed citations

Liu, Shuiyi, Weiqun Chen, Hui Hu, et al.. (2021). Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1. Breast Cancer Research. 23(1). 115–115. 24 indexed citations

Lu, Xiaojuan, et al.. (2021). HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies. Frontiers in Oncology. 11. 685706–685706. 22 indexed citations

Xie, Guomin, Lan‐Juan Zhao, Qian Chen, et al.. (2020). High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations

Wang, Wenlong, et al.. (2020). KRT8 and KRT19, associated with EMT, are hypomethylated and overexpressed in lung adenocarcinoma and link to unfavorable prognosis. Bioscience Reports. 40(7). 40 indexed citations

Lu, Chi‐Cheng, Lei Zhang, Hongbin Wu, & Hongda Lu. (2018). Evaluating risk factors of radiation pneumonitis after stereotactic body radiation therapy in lung tumor: Meta-analysis of 9 observational studies. PLoS ONE. 13(12). e0208637–e0208637. 20 indexed citations

Chen, Lili, Chao Wei, Hongda Lu, et al.. (2018). P2.01-127 Efficacy of Endostar Combined with Whole Brain Radiotherapy in Patients with NSCLC Brain Metastases. Journal of Thoracic Oncology. 13(10). S714–S714. 1 indexed citations

10.

Li, Yuhui, et al.. (2018). Blockade of Aquaporin 4 Inhibits Irradiation-Induced Pulmonary Inflammation and Modulates Macrophage Polarization in Mice. Inflammation. 41(6). 2196–2205. 25 indexed citations

11.

Lu, Chi‐Cheng, Ting Huang, Weiqun Chen, & Hongda Lu. (2015). GnRH participates in the self-renewal of A549-derived lung cancer stem-like cells through upregulation of the JNK signaling pathway. Oncology Reports. 34(1). 244–250. 24 indexed citations

12.

Wu, Tangwei, Weiqun Chen, Shuiyi Liu, et al.. (2014). Huaier suppresses proliferation and induces apoptosis in human pulmonary cancer cells via upregulation of miR‐26b‐5p. FEBS Letters. 588(12). 2107–2114. 70 indexed citations

13.

Jiang, Jun, Liang Fan, Guodong Huang, et al.. (2014). MicroRNA-27b suppresses growth and invasion of NSCLC cells by targeting Sp1. Tumor Biology. 35(10). 10019–10023. 49 indexed citations

14.

Li, Jun, Jian Liu, Xiaogang Mao, Qiu Tang, & Hongda Lu. (2014). IL-7 Receptor Blockade Inhibits IL-17-Producing γδ Cells and Suppresses Melanoma Development. Inflammation. 37(5). 1444–1452. 16 indexed citations

15.

Lu, Hongda. (2013). Clinical Research of Combining Traditional Chinese Medicine with Western Medicine to Treat Non-small Cell Lung Cancer. Zhongguo shiyan fangjixue zazhi. 1 indexed citations

16.

Lu, Hongda, Lei Zhang, Zhongxin Lu, et al.. (2013). Silencing tankyrase and telomerase promotes A549 human lung adenocarcinoma cell apoptosis and inhibits proliferation. Oncology Reports. 30(4). 1745–1752. 16 indexed citations

17.

Lu, Hongda. (2011). Changes of the activities of nonspecific immunity factors of Procambarus clarkii exposed to zinc sulphate. Jiangsu nongye xuebao. 1 indexed citations

18.

Lu, Hongda. (2009). Acute toxicity of zinc sulphate on four hydrocoles in fresh water. Freshwater Fisheries. 1 indexed citations

19.

Lu, Hongda. (2009). The suitable time in the measurement of phenoloxidase activity. Journal of Shanghai Ocean University. 4 indexed citations

20.

Lu, Hongda. (2006). Counting and morphological changes in vitro of haemocytes in Eriocheir sinensis. JOURNAL OF FISHERIES OF CHINA. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact